| Literature DB >> 34220685 |
Martin Cabal1,2, Linda Machova1,3, Daniel Vaclavik4,5, Petr Jasso6, David Holes6,7, Ondrej Volny1,8, Michal Bar1,5.
Abstract
Background and Purpose: Ischemic stroke is a leading cause of mortality and morbidity worldwide. The time from stroke onset to treatment impacts clinical outcome. Here, we examined whether changing a triage model from "drip and ship" to "mothership" yielded significant reductions of onset-to-groin time (OGT) in patients receiving EVT and onset-to-needle time (ONT) in IVT-treated patients, compared to before FAST-PLUS test implementation. We also investigated whether the new triage improved clinical outcomes.Entities:
Keywords: EVT; large vessel occlusion; paramedic; prehospital triage; stroke
Year: 2021 PMID: 34220685 PMCID: PMC8244289 DOI: 10.3389/fneur.2021.676126
Source DB: PubMed Journal: Front Neurol ISSN: 1664-2295 Impact factor: 4.003
Figure 1Flowchart of prehospital triage in the Moravian–Silesian region, Czech Republic, before the triage change. IVT indicates intravenous thrombolysis; EVT, endovascular treatment; and LVO, large vessel occlusion.
Figure 2Flowchart of prehospital triage in the Moravian–Silesian region, Czech Republic, after the triage change. CSC indicates comprehensive stroke center; PSC, primary stroke center; IVT, intravenous thrombolysis; EVT, endovascular treatment; and LVO, large vessel occlusion.
Figure 3Stroke centers in the Moravian–Silesian region of the Czech Republic (gray color). Green circles, PSC; red circle, CSC.
Figure 4Calculated time metrics. OCT indicates onset-to-call time; TT, transfer time; DNT, door-to needle time; DGT, door-to-groin time; ODT, onset-to-door time; ONT, onset-to-needle time; and OGT, onset-to-needle/groin time.
Demographic data and results.
| Total number of treated patients | 431 | 691 | NA | |||
| Number of patients, total (% men) | 364 (54.4) | 89 (56.2) | 654 (52) | 179 (54.7) | NS | NS |
| Age | 72.5 (16.2) | 70 (12) | 74 (16) | 73 (12) | 0.170 | 0.024 |
| Baseline NIHSS | 11 (9.5) | 16 (9) | 9 (11) | 16 (7) | 0.003 | 0.307 |
| Favorable clinical outcome (mRS 0–2), % | 60 | 40 | 59 | 44 | NA | NA |
| DNT, min | 45 (24) | — | 26 (15) | — | <0.001 | NA |
| DGT, min | — | 32,5 (74.2) | — | 60 (35) | NA | 0.023 |
| OCT, min | 15 (54.1) | 9 (11) | 12 (28.3) | 7 (17.6) | 0.024 | 0.515 |
| TT, min | 41 (19.7) | 142 (128.1) | 48 (20.1) | 47 (19.7) | <0.001 | <0.001 |
| ODT, min | 93 (111) | 179 (184.8) | 81 (44.4) | 74 (34.9) | <0.001 | <0.001 |
| ONT, min | 110 (81) | — | 109 (48.7) | — | 0.118 | NA |
| OGT, min | — | 213 (105) | — | 142 (51.5) | NA | <0.001 |
Data presented as median (IQR) unless otherwise indicated.
DNT indicates door-to-needle time; DGT, door-to-groin time; OCT, stroke onset to call of the EMS; TT, transfer time (from the arrival of EMS to a stroke patient to the stroke center); ODT, stroke onset to arrival to the stroke center; ONT, onset-to-needle time (only for IVT patients); and OGT, onset to the catheterization of femoral artery (only for EVT patients).
Figure 5Distribution of mRS values at 3 months for EVT patients in 2015 and 2018.